Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 86.03% is 73% below its 5-year average of 315.88%, near the low end of its 5-year range (75.01%–821.13%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.35% below its 12-month average of 89.02%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): 86.03%.
RETURN ON EQUITY (ROE)
86.03%
RETURN ON EQUITY (ROE) AVG TTM
89.02%
RETURN ON EQUITY (ROE) AVG 3Y
166.91%
RETURN ON EQUITY (ROE) AVG 5Y
315.88%
RETURN ON EQUITY (ROE) AVG 10Y
101.02%
RETURN ON EQUITY (ROE) AVG 15Y
48.41%
RETURN ON EQUITY (ROE) AVG 20Y
28.84%
CURRENT VS TTM AVG
-3.35%
CURRENT VS 3Y AVG
-48.46%
CURRENT VS 5Y AVG
-72.76%
CURRENT VS 10Y AVG
-14.84%
CURRENT VS 15Y AVG
+77.73%
CURRENT VS 20Y AVG
+198.32%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+561.27%
vs the sector median at left
Cencora, Inc.
Market Cap
$62.57B
Return on Equity (ROE)
86.03%
TTM Avg
89.02%
3Y Avg
166.91%
5Y Avg
315.88%
Market Cap
$63.88B
Return on Equity (ROE)
14.71%
TTM Avg
10.21%
3Y Avg
8.16%
5Y Avg
6.40%
Market Cap
$57.13B
Return on Equity (ROE)
-46.61%
TTM Avg
-32.64%
3Y Avg
-13.90%
5Y Avg
0.25%
Market Cap
$54.94B
Return on Equity (ROE)
N/A
TTM Avg
-57.79%
3Y Avg
-38.31%
5Y Avg
2.19%
Market Cap
$74.19B
Return on Equity (ROE)
15.05%
TTM Avg
11.32%
3Y Avg
12.19%
5Y Avg
12.83%
Market Cap
$49.21B
Return on Equity (ROE)
6.65%
TTM Avg
7.05%
3Y Avg
11.93%
5Y Avg
15.09%
Market Cap
$49.00B
Return on Equity (ROE)
3.85%
TTM Avg
6.60%
3Y Avg
6.50%
5Y Avg
6.42%
Market Cap
$48.58B
Return on Equity (ROE)
9.46%
TTM Avg
26.07%
3Y Avg
24.86%
5Y Avg
23.86%
Market Cap
$80.51B
Return on Equity (ROE)
13.65%
TTM Avg
14.72%
3Y Avg
15.95%
5Y Avg
23.11%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cencora, Inc. (COR) | $62.57B | 86.03% | 89.02% | 166.91% | 315.88% |
| Boston Scientific Corporation (BSX)vs › | $63.88B | 14.71% | 10.21% | 8.16% | 6.40% |
| Moderna, Inc. (MRNA)vs › | $57.13B | -46.61% | -32.64% | -13.90% | 0.25% |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | N/A | -57.79% | -38.31% | 2.19% |
| Cigna Corporation (CI)vs › | $74.19B | 15.05% | 11.32% | 12.19% | 12.83% |
| Humana Inc. (HUM)vs › | $49.21B | 6.65% | 7.05% | 11.93% | 15.09% |
| Becton, Dickinson and Company (BDX)vs › | $49.00B | 3.85% | 6.60% | 6.50% | 6.42% |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 9.46% | 26.07% | 24.86% | 23.86% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.51B | 13.65% | 14.72% | 15.95% | 23.11% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 9.10% | -6.34% | -12.86% | -14.53% |
ROE
86.0%
ROA
3.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 86.03% |
| 2026-03-31 | 75.01% |
| 2025-12-31 | 85.16% |
| 2025-09-30 | 103.06% |
| 2025-06-30 | 95.81% |
| 2025-03-31 | 167.19% |
| 2024-12-31 | 616.22% |
| 2024-09-30 | 233.63% |
| 2024-06-30 | 200.64% |
| 2024-03-31 | 171.02% |
| 2023-12-31 | 204.79% |
| 2023-09-30 | 334.35% |
| 2023-06-30 | 246.27% |
| 2023-03-31 | 573.99% |
| 2022-06-30 | 821.13% |
| 2022-03-31 | 313.81% |
| 2021-12-31 | 668.28% |
| 2021-09-30 | 689.46% |
| 2020-06-30 | 40.70% |
| 2020-03-31 | 44.07% |
| 2019-12-31 | 21.98% |
| 2019-09-30 | 29.71% |
| 2019-06-30 | 31.98% |
| 2019-03-31 | 31.83% |
| 2018-12-31 | 39.04% |
| 2018-09-30 | 56.55% |
| 2018-06-30 | 36.49% |
| 2018-03-31 | 28.39% |
| 2017-12-31 | 35.80% |
| 2017-09-30 | 20.08% |
| 2017-06-30 | 33.39% |
| 2017-03-31 | 45.55% |
| 2016-12-31 | 63.54% |
| 2016-09-30 | 67.06% |
| 2016-06-30 | 87.72% |
| 2016-03-31 | 69.05% |
| 2015-12-31 | 30.42% |
| 2015-09-30 | -21.29% |
| 2015-06-30 | -27.38% |
| 2015-03-31 | -34.35% |
| 2014-12-31 | 1.99% |
| 2014-09-30 | 14.13% |
| 2014-06-30 | 13.07% |
| 2014-03-31 | 20.55% |
| 2013-12-31 | 13.63% |
| 2013-09-30 | 18.70% |
| 2013-06-30 | 22.59% |
| 2013-03-31 | 23.83% |
| 2012-12-31 | 31.04% |
| 2012-09-30 | 29.27% |
| 2012-06-30 | 23.99% |
| 2012-03-31 | 23.96% |
| 2011-12-31 | 24.38% |
| 2011-09-30 | 24.65% |
| 2011-06-30 | 21.87% |
| 2011-03-31 | 21.68% |
| 2010-12-31 | 21.81% |
| 2010-09-30 | 21.55% |
| 2010-06-30 | 21.35% |
| 2010-03-31 | 20.53% |
| 2009-12-31 | 19.83% |
| 2009-09-30 | 18.53% |
| 2009-06-30 | 17.53% |
| 2009-03-31 | 9.47% |
| 2008-12-31 | 9.27% |
| 2008-09-30 | 9.25% |
| 2008-06-30 | 8.19% |
| 2008-03-31 | 15.64% |
| 2007-12-31 | 15.83% |
| 2007-09-30 | 15.14% |
| 2007-06-30 | 13.48% |
| 2007-03-31 | 12.05% |
| 2006-12-31 | 12.51% |
| 2006-09-30 | 11.33% |
| 2006-06-30 | 9.96% |
| 2006-03-31 | 8.88% |
| 2005-12-31 | 8.49% |
| 2005-09-30 | 7.77% |
| 2005-06-30 | 8.38% |
| 2005-03-31 | 9.17% |
| 2004-12-31 | 10.07% |
| 2004-09-30 | 10.79% |
| 2004-06-30 | 11.29% |
| 2004-03-31 | 11.32% |
| 2003-12-31 | 11.09% |
| 2003-09-30 | 11.02% |
| 2003-06-30 | 10.72% |
